Showing results (251-260 of 299) with videos related to
Sort By:
Pageof 30
European Journal of Heart Failure|October 30, 2018
Association with outcomes and response to treatment of trimethylamine N-oxide in heart failure: results from BIOSTAT-CHFToru Suzuki, Yoshiyuki Yazaki, Adriaan A Voors, et al.Journal of the American College of Cardiology|February 2, 2018
Biomarker-Guided Versus Guideline-Based Treatment of Patients With Heart Failure: Results From BIOSTAT-CHFWouter Ouwerkerk, Aeilko H Zwinderman, Leong L Ng, et al.International Journal of Cardiology|November 29, 2018
Non-cardiac comorbidities in heart failure with reduced, mid-range and preserved ejection fractionKoen W Streng, Jan F Nauta, Hans L Hillege, et al.The New England Journal of Medicine|April 14, 2017
Effect of Ularitide on Cardiovascular Mortality in Acute Heart FailureMilton Packer, Christopher O'Connor, John J V McMurray, et al.American Heart Journal|May 13, 2015
Rationale, design, and baseline characteristics in Evaluation of LIXisenatide in Acute Coronary Syndrome, a long-term cardiovascular end point trial of lixisenatide versus placeboRhonda Bentley-Lewis, David Aguilar, Matthew C Riddle, et al.Cardiovascular Research|October 1, 2020
Differences in biomarkers and molecular pathways according to age for patients with HFrEFJoão Pedro Ferreira, Wouter Ouwerkerk, Bernadet T Santema, et al.Journal of the American College of Cardiology|September 1, 2018
Identifying Pathophysiological Mechanisms in Heart Failure With Reduced Versus Preserved Ejection FractionJasper Tromp, B Daan Westenbrink, Wouter Ouwerkerk, et al.JACC. Heart Failure|February 10, 2020
Distinct Pathological Pathways in Patients With Heart Failure and DiabetesJasper Tromp, Adriaan A Voors, Abhinav Sharma, et al.European Journal of Heart Failure|June 6, 2017
Mineralocorticoid receptor antagonist pattern of use in heart failure with reduced ejection fraction: findings from BIOSTAT-CHFJoão Pedro Ferreira, Patrick Rossignol, Jean-Loup Machu, et al.European Journal of Heart Failure|October 1, 2025
Global patterns of polypharmacy after acute heart failure hospitalization: Prevalence and outcomes from the REPORT-HF registryWan Ting Tay, Tiew-Hwa Katherine Teng, Wouter Ouwerkerk, et al.Pageof 30